COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02946671
Recruitment Status : Completed
First Posted : October 27, 2016
Last Update Posted : March 6, 2020
Kyowa Kirin Co., Ltd.
Ono Pharmaceutical Co. Ltd
Clinical Study Support, Inc.
Fiverings Co., Ltd.
Information provided by (Responsible Party):
Hisashi Wada, Osaka University

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 2020
Actual Study Completion Date : March 2020